Benzyl (3-hydroxycyclohexyl)carbamate

Catalog No.: 
ACWHPY840
CAS No.: 
955406-36-7
Molecular Formula: 
C14H19NO3
Molecular Weight: 
249.31
Benzyl (3-hydroxycyclohexyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$150.00In stockIn stock
25g95%$728.00InquiryIn stock
100g95%$2376.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl (3-hydroxycyclohexyl)carbamate
IUPAC Namebenzyl (3-hydroxycyclohexyl)carbamate
MDL No.MFCD08061945
Molecular FormulaC14H19NO3
Molecular Weight249.31
SMILESO=C(OCC1=CC=CC=C1)NC2CC(O)CCC2
InChI KeyFYIZIYCXUSGNLZ-UHFFFAOYSA-N
Synonym3-BENZYLOXYCARBONYLAMINO-CYCLOHEXANOL;(3-hydroxy-cyclohexyl)-carbamic acid benzyl ester;Benzyl (3-hydroxycyclohexyl)carbamate;Benzyl (3-hydroxycyclohexyl);Carbamic acid,N-(3-hydroxycyclohexyl)-, phenylmethyl ester
CAS No.955406-36-7
PubChem CID14476840

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWHPY840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEBAS907 route compound structure diagram
    ACEBAS9076850-39-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWHPY840 route product structure diagram
    ACWHPY840955406-36-7In Stock
Inquiry

2. ACWHPY840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYWCL148 route compound structure diagram
    ACYWCL148320590-29-2In Stock
  2. Then
  3. ACWHPY840 route product structure diagram
    ACWHPY840955406-36-7In Stock
Inquiry

3. ACWHPY840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHPY840 route product structure diagram
    ACWHPY840955406-36-7In Stock
Inquiry

Comments (0)